Talk about a job hopper though. I think we will be lucky to get two years out of him. Missing dependable Carter. At whatever point Nasrat decides to sell the company I hope the list of drugs Elite is working on is impressive enough for him to get more than the current share price. Part of the issue here is we have no idea of their possible pipeline. We are flying bind.
News 
Market Data 
Discover 
AI
